- Clinical efficacy and safety of basal insulin analogue glargine in patients with type 2 diabetes mellitus2016 | First Faculty of Medicine
- Six-month experience with the basal insulin analogue detemir2006 | Faculty of Medicine in Pilsen
- Insulin glargine: a proven basal insulin analogue2014 | Second Faculty of Medicine
- Dawn phenomenon2017 | Second Faculty of Medicine
- Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial2008 | Second Faculty of Medicine, Central Library of Charles University
- Less discussed aspects in the choice of basal insulin2021 | Second Faculty of Medicine
- Practical experience with a degludec/liraglutide fixed-ratio combination therapy2019 | First Faculty of Medicine
- Lixisenatide - a novel prandial GLP-1 receptor agonist2013 | Second Faculty of Medicine
- Degludec - a new ultralong insulin analogue2014 | Faculty of Medicine in Hradec Králové
- Adherence of type 2 dibetes patients on insulin analogues application: missed dose, time inmprecision and dose reduction2014 | First Faculty of Medicine
- Insulin treatment options in 20152015 | Second Faculty of Medicine
- Basal insulin glargine using a basal-bolus regimen in a common clinical practice: observational, non-interventional, multicenter, national project LINDA (Lantus in daily practice - safety and efficacy in basal bolus regimen)2014 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Deintensification to a fixed mixture of insulin glargine and lixisenatide as a way to modern antidiabetic therapy in patients with type 2 diabetes mellitus2020 | First Faculty of Medicine
- Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review2020 | First Faculty of Medicine
- Comparison of insulin degludec with insulin glargine in insulin-naive subjects with type 2 diabetes: a 2-year randomized, treat-to-target trial2013 | Second Faculty of Medicine